EMGRX
Price
$10.34
Change
-$0.29 (-2.73%)
Updated
Feb 21 closing price
Net Assets
161.75M
VSCIX
Price
$114.80
Change
-$3.11 (-2.64%)
Updated
Feb 21 closing price
Net Assets
160.88B
Ad is loading...

EMGRX vs VSCIX

Header iconEMGRX vs VSCIX Comparison
Open Charts EMGRX vs VSCIXBanner chart's image
Nuveen Small Cap Select A
Price$10.34
Change-$0.29 (-2.73%)
VolumeN/A
Net Assets161.75M
Vanguard Small Cap Index I
Price$114.80
Change-$3.11 (-2.64%)
VolumeN/A
Net Assets160.88B
EMGRX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMGRX vs. VSCIX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMGRX is a Hold and VSCIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 161B vs. EMGRX (162M). VSCIX pays higher dividends than EMGRX: VSCIX (1.43) vs EMGRX (0.00). EMGRX was incepted earlier than VSCIX: EMGRX (33 years) vs VSCIX (28 years). EMGRX is a more actively managed with annual turnover of: 42.00 vs. VSCIX (12.00). EMGRX has a lower initial minimum investment than VSCIX: EMGRX (3000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 14.26 vs. EMGRX (10.29). VSCIX return over 5 years is better than : 48.39 vs. EMGRX (29.22).
EMGRXVSCIXEMGRX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence33 years28 years-
Gain YTD1.0462.39744%
Front LoadN/AN/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets162M161B0%
Annual Yield % from dividends0.001.43-
Returns for 1 year10.2914.2672%
Returns for 3 years21.2622.0896%
Returns for 5 years29.2248.3960%
Returns for 10 years-5.61111.39-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSY0.99N/A
+0.01%
SunLink Health Systems
MRCY42.51-0.55
-1.28%
Mercury Systems
TWLO114.31-3.69
-3.13%
Twilio
DNA10.82-0.61
-5.34%
Ginkgo Bioworks Holdings
TARA3.72-0.23
-5.82%
Protara Therapeutics